Days Inventory is also known as Days Sales of Inventory (DSI). Emmaus Life Sciences's Average Total Inventories for the
three
months ended in Sep. 2023 was $1.73 Mil. Emmaus Life Sciences's Cost of Goods Sold for the
three
months ended in Sep. 2023 was $0.21 Mil.
Hence, Emmaus Life Sciences's Days Inventory for the
three
months ended in Sep. 2023 was 738.53.
The historical rank and industry rank for Emmaus Life Sciences's Days Inventory or its related term are showing as below:
EMMA'
s Days Inventory Range Over the Past 10 Years
Min: 438.89 Med: 927.49 Max: 2659.43
Current: 438.89
During the past 13 years, Emmaus Life Sciences's highest Days Inventory was 2659.43. The lowest was 438.89. And the median was 927.49.
EMMA's Days Inventory is ranked worse than 79.82% of 649
companies
in the Biotechnology industry
Industry Median: 191.36
vs EMMA: 438.89
Emmaus Life Sciences's Days Inventory
increased
from Sep. 2022 (496.21) to Sep. 2023 (738.53).
It might indicate that Emmaus Life Sciences's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Emmaus Life Sciences's Inventory Turnover for the
three
months ended in Sep. 2023 was 0.12.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Emmaus Life Sciences's Inventory-to-Revenue for the
three
months ended in Sep. 2023 was 0.35.
Emmaus Life Sciences Days Inventory Historical Data
The historical data trend for Emmaus Life Sciences's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Emmaus Life Sciences's Days Inventory
For the Biotechnology subindustry, Emmaus Life Sciences's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Emmaus Life Sciences's Days Inventory Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Emmaus Life Sciences's Days Inventory distribution charts can be found below:
* The bar in red indicates where Emmaus Life Sciences's Days Inventory falls into.
Emmaus Life Sciences Days Inventory Calculation
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Emmaus Life Sciences's Days Inventory for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Emmaus Life Sciences (OTCPK:EMMA) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Emmaus Life Sciences's Inventory Turnover for the
three
months ended in Sep. 2023 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Emmaus Life Sciences's Inventory to Revenue for the
three
months ended in Sep. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Emmaus Life Sciences Days Inventory Related Terms
Thank you for viewing the detailed overview of Emmaus Life Sciences's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Emmaus Life Sciences (Emmaus Life Sciences) Business Description
Emmaus Life Sciences Inc is a biopharmaceutical company engaged in the discovery, development, and commercialization of new treatments and therapies primarily for rare and orphan diseases. The company's commercial product is Endari, an oral pharmaceutical grade L-glutamine treatment indicated to reduce acute complications of sickle cell disease in adult and pediatric patients five years of age and older. Its products in the pipeline include Diverticulosis and Cell Sheet Engineering.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
EMMA has been successfully added to your 